MedPath

Enhanced Recovery Open Versus Laparoscopic Donor Nephrectomy

Phase 3
Completed
Conditions
Renal Transplant Donor of Left Kidney
Interventions
Procedure: Open donor nephrectomy
Procedure: Laparoscopic donor nephrectomy
Registration Number
NCT02699489
Lead Sponsor
Mansoura University
Brief Summary

A phase III randomized trial conducted to compare recovery outcomes between laparoscopic and open donor nephrectomy within a specified enhanced recovery protocol

Detailed Description

The MEnROL trial is a phase III randomized controlled trial of Open versus Laparoscopic donor nephrectomy within a standardized enhanced recovery program. Eligible donors were randomized in a 1:1 ratio.

Laparoscopic procedures are performed by a single surgeon (AMM) while Open donor nephrectomies (ODN) were performed by an experienced team that included the laparoscopic surgeon. ODN were performed via a supracostal incision above the 11th rib and an extra-pleural extra-peritoneal approach was adopted. Laparoscopic donor nephrectomy (LDN) was performed via a standard 4-port distribution. Control of the hilar vessels was performed using extra-large Hem-o-Lok clips (Weck- Covidien, Research Triangle Park, NC) and graft extraction was performed via a pre-prepared Pfannenstiel incision.

Donors are enrolled in our enhanced recovery program for donor nephrectomy. The program was compliant with the Enhanced Recovery After Surgery Group (ERAS) guidelines. All donors receive epidural analgesia and are maintained on non-narcotic postoperative analgesics. Criteria for hospital discharge include ambulation, adequate pain control with oral analgesics, and sustained intake of solid food.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
224
Inclusion Criteria
  1. Donor aged 18 years or more.
  2. Donors who have the ability to understand information and materials provided.
  3. Donors who didn't express a preference for either open or laparoscopic surgery.
  4. Donors who are fit for both open and laparoscopic intervention
  5. Donors in whom evaluation revealed left kidney with single renal artery suitable for donation.
  6. Donors able to give signed written informed consent.
Exclusion Criteria
  1. Donors who had a preference for either open or laparoscopic surgery.
  2. Donors in whom the right kidney was chosen for donation.
  3. Donors with double renal arteries in kidneys chosen for donation.
  4. Donors who didn't sign consent.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Open donor nephrectomy armOpen donor nephrectomyThis group will undergo open donor nephrectomy
Laparoscopic donor nephrectomy armLaparoscopic donor nephrectomyThis group will undergo laparoscopic donor nephrectomy
Primary Outcome Measures
NameTimeMethod
Donor recovery as evaluated by the physical fatigue domain of the Multidimensional Fatigue Inventory 20 (MFI-20),6 weeks
Secondary Outcome Measures
NameTimeMethod
Length of Hospital stayup to 2 weeks

Length of hospital stay in days

Duration of the procedureup to 24 hours

Duration of the procedure in minutes

Peri-operative complications90 days

Incidence of peri-operative complications in both groups

Recipient complications90 days

Incidence of recipient complications in both groups

Ischemia timesup to 1 day

Warm and Cold ischemia times in minutes

One year graft loss1 year

Incidence of one year graft loss in both groups

Short Form-36 (SF-36) health survey6 weeks

Scores of Short Form-36 questionnaire

© Copyright 2025. All Rights Reserved by MedPath